Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Schering-Plough Integrated Therapeutics Group |
---|---|
Information provided by: | Schering-Plough |
ClinicalTrials.gov Identifier: | NCT00070707 |
An association between seasonal allergic rhinitis (SAR) and allergic asthma has been established through epidemiologic, pathophysiologic, and therapeutic studies. This study will compare Nasonex Nasal Spray to Placebo in treating the nasal and asthma symptoms experienced by subjects with SAR and concomitant asthma.
Condition | Intervention | Phase |
---|---|---|
Rhinitis, Allergic, Seasonal Asthma |
Drug: Nasonex |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study |
Ages Eligible for Study: | 15 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Eligibility Criteria:
Exclusion Criteria:
Study ID Numbers: | P03280 |
Study First Received: | October 7, 2003 |
Last Updated: | May 31, 2006 |
ClinicalTrials.gov Identifier: | NCT00070707 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Seasonal Allergic Rhinitis Concomitant Asthma |
Anti-Inflammatory Agents Otorhinolaryngologic Diseases Bronchial Diseases Mometasone furoate Asthma Rhinitis Anti-Allergic Agents Lung Diseases, Obstructive |
Hypersensitivity Respiratory Tract Diseases Respiratory Tract Infections Rhinitis, Allergic, Seasonal Lung Diseases Hypersensitivity, Immediate Respiratory Hypersensitivity |
Anti-Inflammatory Agents Otorhinolaryngologic Diseases Bronchial Diseases Immune System Diseases Mometasone furoate Asthma Rhinitis Anti-Allergic Agents Pharmacologic Actions Nose Diseases |
Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Infections Respiratory Tract Diseases Therapeutic Uses Rhinitis, Allergic, Seasonal Lung Diseases Hypersensitivity, Immediate Respiratory Hypersensitivity |